Proscia’s AI Pathology Platform Sees 400% Growth in Daily Cases
Proscia is scaling its AI-powered Concentriq pathology platform, driving adoption through a variety of clinical and business benefits.
Read More
Search Results for: prostate cancer
Saliva Analysis Could Reveal Disease Risk
A study shows that saliva contains genetic markers linked to systemic diseases for a non-invasive alternative to blood-based diagnostics.
Read More
Test Predicts Which Patients Will Not Respond to Chemotherapy
Researchers have developed genomic biomarkers to predict cancer patients’ resistance to chemotherapy, enabling more personalized treatment.
Read More
Nanoneedle Patch Could Replace Painful Cancer Biopsies
A nanoneedle patch offers a painless, non-invasive alternative to biopsies by collecting molecular information without removing tissue.
Read More
Quest Diagnostics to Develop MCaST Blood Test
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More